Explore FHI 360

Practice Area

Research

There is an art to improving lives. And it’s in our science.

Published research

Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in Sub-Saharan Africa

Published research

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

Project

Innovate FP: Expanding Options, Enhancing Method Choice

Innovate FP is a contraceptive research project to expand desirable, affordable, quality contraceptive options to better meet the needs of women.

News

Award will continue work to advance contraceptive technology innovation

The Bill & Melinda Gates Foundation granted a four-year award to expand and strengthen ongoing development and evaluation of new contraceptives, under the Contraceptive Technology Innovation (CTI) Initiative.

Published research

Menstrual bleeding changes are NORMAL: Proposed counseling tool to address common reasons for non-use and discontinuation of contraception

The authors reviewed commonly used family planning counseling, training and reference materials and found that menstrual bleeding changes were insufficiently addressed. The authors suggest using a new counseling mnemonic tool, “NORMAL,” that provides messages about changes associated with the use of hormonal contraception and the copper IUD.

Tools

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Article Types

Resource Types

Research

Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in Sub-Saharan Africa

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

Innovate FP: Expanding Options, Enhancing Method Choice

Award will continue work to advance contraceptive technology innovation

Menstrual bleeding changes are NORMAL: Proposed counseling tool to address common reasons for non-use and discontinuation of contraception

Pathways to High Adherence: An Adherence Support Manual for Vaginal Ring Trials

Envision FP

Contraceptive Technology Innovation (CTI) Initiative

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Article Types

Resource Types

Search within these results

9 Results Found

Menstrual bleeding changes are NORMAL: Proposed counseling tool to address common reasons for non-use and discontinuation of contraception